Reading CVSA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CVSA free→Reading CVSA? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CVSA free→NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-06-15
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but management's recent track record is neutral and capital-unfriendly. Earnings quality is neutral, and risk is high, while the sector backdrop presents a headwind. Compared with sector peers, CVSA is above typical. Peer multiples imply a price about 6% above where it trades (it looks cheap on this basis); the read is fair. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $117.56. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $118 CVSA trades at 15× p/e, below its 15× p/e peer median. Our $126 fair value sits above the price; high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 7% below a flat-multiple fair value, below our forecast of about 8%. This describes what's priced in, not a forecast of the move.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated strong grew net income 70% of the time over the next year (vs 53% for the rest of the cohort, n=2844).
Over the trailing year it converted 1.74x of net income into operating cash flow. Historically, Consumer Discretionary names rated neutral grew net income 52% of the time over the next year (vs 55% for the rest of the cohort, n=3229).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.93 → $1.89 (-1.9% / 30d). 0 raised, 1 cut, 4 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 100% of analysts rate Buy.
Divergence: fundamentals are strong but estimates are being cut. Worth reading the recent material events.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$140.
How much price usually moves either way.
On a bad day, this stock has moved -$305.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,214.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Valuation rose by 12.3 points (from 40.9 to 53.2).
As of June 15, 2026, valuation rose. This change indicates a shift in how the stock is valued relative to its peers. The sector backdrop remains a headwind, which may impact overall performance. Risk remains high, suggesting ongoing concerns in the market environment.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Higher revenue guidance shows confidence in sales growth and market demand.
Confirms:Management raises revenue guidance for FY 2026. It is now beyond current estimates.
Disproves:Management keeps or lowers revenue guidance for FY 2026.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CVSA yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition On May 7, 2026, Covista Inc. (“Covista”) issued a press release announcing its third quarter fiscal 2026 academic, operating and financial results. The press release is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exc…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Roughly priced in line with peers.
Around its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
A side-by-side read on sector standing, valuation, and risk versus Education Services.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CVSA Covista Inc. | Above typical Show detailsSector percentile: 96 of 100 | fair | high |
EDU NEW ORIENTAL EDUCATION and TECHNOLOGY GROUP INC | — | — | elevated |
DUOL Duolingo | Typical Show detailsSector percentile: 67 of 100 | fair | elevated |
LAUR Laureate Education, Inc. | Typical Show detailsSector percentile: 47 of 100 | full | moderate |
GHC Graham Holdings | Above typical Show detailsSector percentile: 79 of 100 | full | moderate |
5 material management or governance events in the past 24 months, led by legal/regulatory items. Historically, Consumer Discretionary names rated neutral grew net income 54% of the time over the next year (vs 57% for the rest of the cohort, n=646).
Not investment advice. As of 2026-06-15.
via XLY
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Covista aims to increase its adjusted earnings per share guidance for fiscal year 2026.
Covista aims to increase its revenue guidance for fiscal year 2026.
Covista is focusing on growing its operating income.
Why it matters: If revenue growth exceeds 8%, it shows strong demand and effective execution. This could boost investor confidence.
Confirms:Q3 FY 2026 revenue growth reported above 8% year over year.
Disproves:Q3 FY 2026 revenue growth reported below 8% year over year.
Why it matters: Doing well would help Covista in healthcare education.
Confirms one read:Management says they are making good progress on the Purpose at Scale strategy.
Confirms the other:Management says there are delays or setbacks in the Purpose at Scale strategy.
Why it matters: Consumer spending data can affect revenue growth. It also impacts market conditions.
Confirms one read:The Advance Monthly Retail Trade Report shows consumer spending growth over 1%.
Confirms the other:Advance Monthly Retail Trade Report shows consumer spending decline or flat growth.
Why it matters: New partnerships can help Covista connect graduates with jobs. This boosts enrollment and revenue.
Confirms:Announcement of new partnerships with at least two healthcare systems.
Disproves:No new partnerships announced within the next six months.
Why it matters: A rise above $8.15 shows strong earnings and success. This can attract investors.
Confirms:Adjusted EPS guidance raised above $8.15.
Disproves:Adjusted EPS guidance remains at or below $8.15.
Why it matters: More unemployment claims could mean the economy is weak. This may hurt consumer spending and Covista's sales.
Confirms:Unemployment claims have risen a lot compared to the last few weeks.
Disproves:Unemployment claims are going down or staying the same.
Regulation FD Disclosure On April 9, 2026, Covista Inc. (“Covista”) released an investor newsletter, which provided updates on key milestones, strategic developments, and operational progress. The investor newsletter is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended…
Entry into a Material Definitive Agreement On March 2, 2026, Covista Inc. (formerly known as Adtalem Global Education Inc.) (“Covista”, the “Company”, or “we”) entered into Amendment No. 5 to Credit Agreement and Incremental Assumption Agreement, dated as of March 2, 2026 (the “Amendment”), by and among the Company, as borrower, the guarantors party thereto, the lender party thereto and Morgan Stanley Senior Funding, Inc. (“MSSF”), as administrative agent (in such capacity, the “Administrat…
Termination of a Material Definitive Agreement On February 13, 2026, the Trustee sent a conditional notice of redemption on behalf of Covista to the holders of the Notes, relating to the redemption in full of the Notes outstanding as of March 2, 2026 (the “Redemption Date”). In connection therewith, on the Redemption Date, Covista deposited with the Trustee funds sufficient to redeem all Notes outstanding on the Redemption Date. The redemption payment (the “Redemption Payment”) included app…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information required by this item is included in